Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Roger B. Davis, Sc.D.

Co-Author

This page shows the publications co-authored by Roger Davis and Irving Kirsch.
Connection Strength

0.375
  1. Open-label versus double-blind placebo treatment in irritable bowel syndrome: study protocol for a randomized controlled trial. Trials. 2017 05 25; 18(1):234.
    View in: PubMed
    Score: 0.178
  2. Open-label placebo vs double-blind placebo for irritable bowel syndrome: a randomized clinical trial. Pain. 2021 09 01; 162(9):2428-2435.
    View in: PubMed
    Score: 0.060
  3. Conscientiousness is modified by genetic variation in catechol-O-methyltransferase to reduce symptom complaints in IBS patients. Brain Behav. 2015 Jan; 5(1):39-44.
    View in: PubMed
    Score: 0.037
  4. Polymorphisms in catechol-O-methyltransferase modify treatment effects of aspirin on risk of cardiovascular disease. Arterioscler Thromb Vasc Biol. 2014 Sep; 34(9):2160-7.
    View in: PubMed
    Score: 0.036
  5. Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome. BMJ. 2008 May 03; 336(7651):999-1003.
    View in: PubMed
    Score: 0.024
  6. Sham device v inert pill: randomised controlled trial of two placebo treatments. BMJ. 2006 Feb 18; 332(7538):391-7.
    View in: PubMed
    Score: 0.020
  7. Investigating placebo effects in irritable bowel syndrome: a novel research design. Contemp Clin Trials. 2006 Apr; 27(2):123-34.
    View in: PubMed
    Score: 0.020
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.